Does SEMAGLUTIDE Cause Therapy cessation? 167 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 167 reports of Therapy cessation have been filed in association with SEMAGLUTIDE (WEGOVY). This represents 0.3% of all adverse event reports for SEMAGLUTIDE.
167
Reports of Therapy cessation with SEMAGLUTIDE
0.3%
of all SEMAGLUTIDE reports
2
Deaths
37
Hospitalizations
How Dangerous Is Therapy cessation From SEMAGLUTIDE?
Of the 167 reports, 2 (1.2%) resulted in death, 37 (22.2%) required hospitalization, and 11 (6.6%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SEMAGLUTIDE. However, 167 reports have been filed with the FAERS database.
What Other Side Effects Does SEMAGLUTIDE Cause?
Nausea (10,036)
Vomiting (6,518)
Off label use (5,425)
Diarrhoea (5,331)
Decreased appetite (4,317)
Constipation (4,036)
Weight decreased (3,518)
Impaired gastric emptying (2,622)
Product use in unapproved indication (2,613)
Wrong technique in product usage process (2,538)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which SEMAGLUTIDE Alternatives Have Lower Therapy cessation Risk?
SEMAGLUTIDE vs SEMUSTINE
SEMAGLUTIDE vs SENNA LEAF
SEMAGLUTIDE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SEMAGLUTIDE vs SENNOSIDES
SEMAGLUTIDE vs SENNOSIDES A AND B